astrazeneca oral glp 1 divulges new GLP-1R agonists AstraZeneca Expands into Obesity with

Best of Berberine is its most recent launch in the category

Liraglutide modulates gut Microbiome and attenuates nonalcoholic fatty liver in db/db mice

Additionally, the threshold to define unhealthy muscle mass has been debated

10.1002/jbmr.2564 Summary Keywords glucagonlike peptide1 receptor agonist, randomized controlled trial, older adults, bone mineral density, bone turnover Citation Dinkla L, Beavers KM, Robbins R, Akpalu D, Wherry SJ, Miller G, Beavers DP, Espinoza S, Trejo J, Stepanenko A and Cortes TM (2025) Bone mineral density and turnover response to GLP-1 receptor agonists in older adults with overweight/obesity and prediabetes/type 2 diabetes: a 20-week pilot trial post hoc analysis

Sept 11: Israelbased BioLineRx won FDA approval for Aphexda (motixafortide), a stem cell mobilization agent for patients with multiple myeloma scheduled for autologous stem cell transplantation (ASCT)

Optimal order: Vegetables (fiber, volume) 5-10 min Protein (meat, fish, eggs) 5-10 min Carbohydrates (rice, pasta, bread) end of meal Why it works: Fiber slows down carbohydrate absorption Proteins trigger GLP-1 first Stomach already partially full = fewer carbohydrates consumed Study: Postprandial blood glucose reduced by 30% with this order (vs